Acquirer
Bristol-Myers Squibb
Bristol-Myers Squibb appears as the named buyer in 5 recorded transactions between 2014 and 2025, most often in healthcare & life sciences.
Record
What Bristol-Myers Squibb has bought
Every recorded transaction where Bristol-Myers Squibb is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| 2seventy bio | Healthcare & Life Sciences | — | 2025-03-10 | $286m |
| Cormorant Pharmaceuticals AB | Healthcare & Life Sciences | — | 2016-07-05 | $95m |
| Padlock Therapeutics | Healthcare & Life Sciences | — | 2016-03-23 | $225m |
| Cardioxyl Pharmaceuticals | Healthcare & Life Sciences | — | 2015-11-02 | $300m |
| F-star Alpha Ltd. | Healthcare & Life Sciences | — | 2014-10-28 | $475m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.